India, May 13 -- Shares of pharma ingredient maker jumped nearly 7% after the company reported its best-ever quarterly performance in Q4FY26. Ace investors Vijay Kedia, who holds a 1.01% stake, and Mukul Agarwal, who holds a 3.12% stake, are among the well-known names backing this stock. The Hyderabad-based company, which makes drug ingredients for pharma companies worldwide, saw its revenue and profits surge on the back of strong demand from its contract manufacturing business.

With a market cap of Rs. 21,348 Crore, the shares of Neuland Laboratories Ltd. are trading at a price of Rs. 16,550 per share i.e. 2.66% down from its previous closing price of Rs. 17,003. In Wednesday's trading session it went up to Rs. 18,300 i.e. approx 7.5% u...